RK

Rohit Kumar

Active Director Director DIN 06779025
DIN 06779025 First appointment Jan 2014 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2014
Shareholding value •••• Premium profile

About Rohit Kumar

Data last updated:

Rohit Kumar is a Director at Eviza Biotech Private Limited (since 2014). The company operates in Trading. Eviza Biotech Private Limited reported revenue of ₹2.51 Cr (FY 2025).

DIN 06779025
Primary Designation Director
Industry Trading
First Appointment 28 Jan 2014
Oldest Company Age 12 yrs
Largest company Eviza Biotech Private Limited · ₹2.51 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Eviza Biotech Private Limited U24232CH2014PTC034940
Director28 Jan 20142014₹2.51 Cr (FY 2025)Active

Board colleagues of Rohit Kumar

NameDINCompanyDesignation
Suresh Kumar05153686Eviza Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Eviza Biotech Private Limited
Premium access

Shareholding and investment profile for Rohit Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rohit Kumar

Rohit Kumar currently holds 1 directorship: Eviza Biotech Private Limited (Director, since 28 Jan 2014, revenue ₹2.51 Cr (FY 2025)).

Rohit Kumar was first appointed on 28 Jan 2014 as Director at Eviza Biotech Private Limited.

The current boards of Rohit Kumar's companies include Suresh Kumar (Eviza Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available